Simple non-invasive biomarkers of advanced fibrosis in the evaluation of non-alcoholic fatty liver disease

Gastroenterology Report

Volumn 2, Issue 4, 2014, Pages 276-280

  Tapper, Elliot B ^a   Krajewski, Katherine ^a   Lai, Michelle ^a   Challies, Tracy ^a   Kane, Robert ^a   Afdhal, Nezam ^a   Lau, Daryl ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Aspartate aminotransferase to platelet ratio index; Cirrhosis; non alcoholic fatty liver disease; Non alcoholic steatohepatitis

Indexed keywords

EID: 84921497619     PISSN: None     EISSN: 20520034     Source Type: Journal    
DOI: 10.1093/gastro/gou034     Document Type: Article

References (15)

1. Chalasani N, Younossi Z, Lavine JE et al. The diagnosis and management of non-Alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012;55:2005-23.
2. Adams LA, Lymp JF, St Sauver J et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005;129:113-21.
3. Williams CD, Stengel J, Asike MI et al. Prevalence of non-Alcoholic fatty liver disease and non-Alcoholic steatohepatitis among a largely middle-Aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011;140:124-31.
4. Hamaguchi M, Kojima T, Takeda N et al. Non-Alcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol 2007;13:1579-84.
5. Ekstedt M, Franzen LE, Mathiesen UL et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006; 44:865-73.
6. Feldstein AE, Charatcharoenwitthaya P, Treeprasertsuk S et al. The natural history of non-Alcoholic fatty liver disease in children: a follow-up study for up to 20 years. Gut 2009;58:1538-44.
7. Hernaez R, Lazo M, Bonekamp S et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-Analysis. Hepatology 2011;54:1082-90.
8. Brunt EM, Janney CG, Di Bisceglie AM et al. Non-Alcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999;94:2467-74.
9. Kleiner DE, Brunt EM, Van natta M et al. Design and validation of a histological scoring system for non-Alcoholic fatty liver disease. Hepatology 2005;41:1313-21.
10. Yang JD, Abdelmalek MF, Pang H et al. Gender and menopause impact severity of fibrosis among patients with non-Alcoholic steatohepatitis. Hepatology 2014;59:1406-14.
11. Kruger FC, Daniels CR, Kidd M et al. APRI: a simple bedside marker for advanced fibrosis that can avoid liver biopsy in patients with NAFLD/NASH. S Afr Med J 2011;101:477-80.
12. Fujii H, Enomoto M, Fukushima W et al. Non-invasive laboratory tests proposed for predicting cirrhosis in patients with chronic hepatitis C are also useful in patients with non-Alcoholic steatohepatitis. J Gastroenterol 2009;44:608-14.
13. McPherson S, Stewart SF, Henderson E et al. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-Alcoholic fatty liver disease. Gut 2010;59: 1265-9.
14. Kim D, Kim WR, Kim HJ et al. Association between non-invasive fibrosis markers and mortality among adults with non-Alcoholic fatty liver disease in the United States. Hepatology 2013;57:1357-65.
15. Angulo P, Hui JM, Marchesini G et al. The NAFLD fibrosis score: a non-invasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 2007;45:846-54.